DNAprint Genomics (DNAG)

[dr frudaky]

Gcbr



The only puzzle I see is why, with all the great things DNAG is supposed to be doing and all that interest in predictive medicine, the investing public has apparently rejected DNAG as a future viable player and ground floor opportunity in this developing field of technology?

Perhaps you should spend more of your time on this question rather than blowing smoke with all those articles and prs' which, to date, have only caused the pps to continue its apparently irreversible downward course. There cannot be any happy campers here, save a few delusionals in denial.

JMHO

dr f